NEW YORK (GenomeWeb) – Congenica has sold the first license to its Sapientia platform to Central Manchester University Hospitals NHS Foundation Trust's (CMFT) Manchester Centre for Genomic Medicine (MCGM).
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.
The New York Times Magazine examines gender discrimination at the Salk Institute.
A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.
In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.
This webinar will discuss the implementation of an enterprise-wide clinical genomics platform that is shared across 10 hospitals and research organizations in the Australian State of Victoria.